EPHB4 and neoplasm: To examine whether synchronous suppression of Dll4/Notch and EphB4/Ephrin-B2 signaling pathways might result in greater inhibition of RT2 tumor development, we treated RT2 Dll4+/- mice with sEphB4-Alb.